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The HIV-1 Gag protein orchestrates all steps of virion
genesis, including membrane targeting and RNA
recruitment into virions. Using crosslinking-immuno-
precipitation (CLIP) sequencing, we uncover several
dramatic changes in the RNA-binding properties of
Gag that occur during virion genesis, coincident
with membrane binding, multimerization, and pro-
teolytic maturation. Prior to assembly, and after
virion assembly and maturation, the nucleocapsid
domain of Gag preferentially binds to psi and Rev
Response elements in the viral genome, and GU-
rich mRNA sequences. However, during virion gene-
sis, this specificity transiently changes in a manner
that facilitates genome packaging; nucleocapsid
binds to many sites on the HIV-1 genome and to
mRNA sequenceswith a HIV-1-like, A-rich nucleotide
composition. Additionally, we find that the matrix
domain of Gag binds almost exclusively to specific
tRNAs in the cytosol, and this association regulates
Gag binding to cellular membranes.
INTRODUCTION
The HIV-1 Gag protein coordinates all major steps in virion as-
sembly. In so doing, it changes subcellular localization andmulti-
merization state and becomes proteolytically processed (Bell
and Lever, 2013; Sundquist and Kra¨usslich, 2012). One function
of Gag is to selectively package a dimeric, unspliced viral RNA
genome selected from a pool of excess cellular RNAs and
spliced viral mRNAs (Kuzembayeva et al., 2014; Lu et al.,
2011b; Rein et al., 2011). Genome packaging requires binding
of the nucleocapsid (NC) domain to viral genomic RNA (Aldovini
and Young, 1990; Berkowitz et al., 1993; Gorelick et al., 1990).
Selection of the viral genome is thought to be governed by a
cis-acting packaging element, psi (J), within the 50 leader of
the viral genome, composed of sequences in the unique 50 region
(U5) and between the tRNA primer binding site (PBS) and the
50 portion of the Gag open reading frame (ORF) (Aldovini and
Young, 1990; Clavel and Orenstein, 1990; Lever et al., 1989;1096 Cell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc.Luban and Goff, 1994). This element is highly structured (Clever
et al., 1995; Harrison and Lever, 1992; McBride and Panganiban,
1996) and may exist in two conformations that favor translation
versus dimerization and packaging (Lu et al., 2011a).
Knowledge of the viral RNA sequences that are directly
bound by Gag is largely inferred from determinations of func-
tional packaging signals in genetic studies, complemented by
limited in vitro data. No assay has yet demonstrated a direct
interaction between Gag andJ in a biologically relevant setting,
i.e., in cells or virions. Additionally, some findings suggest that
sequences outside J might facilitate genome packaging. First,
disruption of J does not eliminate specific RNA encapsida-
tion (Clever and Parslow, 1997; Laham-Karam and Bacharach,
2007; McBride and Panganiban, 1997). Second, sequences
outside J can increase HIV-1 vector titers or virion RNA levels
(Berkowitz et al., 1995; Chamanian et al., 2013; Das et al., 1997;
McBride et al., 1997; Richardson et al., 1993). Third, virions
can package cellular RNAs (Muriaux et al., 2001; Rulli et al.,
2007), lacking a J sequence, particularly in the absence of
viral RNA. The RNA properties that underlie these findings are
unknown.
HIV-1 Gag molecules exist as monomers or low-order multi-
mers in the cell cytosol and form higher-order multimers only
after binding to the plasma membrane (Kutluay and Bieniasz,
2010). Imaging studies indicate that small numbers of Gag mol-
ecules recruit a single viral RNA dimer to the plasma membrane,
nucleating the assembly of thousands of Gag molecules into an
immature virion (Jouvenet et al., 2009). Thereafter, Gag proteol-
ysis liberates NC and other Gag domains, triggering virion matu-
ration. Whether these changes in Gag/NC configuration affect its
RNA-binding properties is unknown, but there is clear potential
for the RNA binding specificity of Gag to change during virion
genesis.
Although NC is thought to be the primary Gag domain that
binds to viral RNA, the matrix (MA) domain can also bind RNA
in vitro (Alfadhli et al., 2009; Chukkapalli et al., 2010; Cimarelli
and Luban, 1999; Levin et al., 2010; Ott et al., 2005; Ramalingam
et al., 2011). N-terminal basic amino acids in MA that mediate
membrane binding also drive in vitro RNA binding (Chukkapalli
et al., 2010, 2013; Hill et al., 1996; Saad et al., 2006; Shkriabai
et al., 2006; Zhou et al., 1994). Because RNA is better able to
blockMA binding tomembranes that are devoid of phosphatidy-
linositol-(4,5)-bisphosphate PI(4,5)P2 (Chukkapalli et al., 2010,
2013; Dick et al., 2013), RNAmight help to target particle assem-
bly to the plasma membrane. However, RNA binding by MA is
not thought to be specific, and whether it actually occurs in cells
is unknown.
To obtain a complete account of the RNA sequences bound by
Gag during virion genesis, we employed crosslinking-immuno-
precipitation-sequencing PAR-CLIP and HITS-CLIP techniques
(Hafner et al., 2010; Licatalosi et al., 2008). We find that cytosolic
Gag binds to three sequence elements within the 50 leader of the
viral genome, which are brought together in a secondary struc-
ture that defines a minimal J element. We also find that cyto-
solic Gag binds to additional discrete sites on the viral genome,
including the Rev Response Element (RRE). Gag association
with the plasma membrane and its assembly into immature
virions trigger a profound change in RNA binding specificity
that favors genome packaging. Subsequently, particle matura-
tion largely reverses this change. Finally, we find that MA is a
bona fide RNA binding domain that selects a subset of tRNAs
in the cystosol, which regulate Gag-membrane binding. Overall,
these studies provide a dynamic, quantitative, and high-resolu-
tion account of the global changes in Gag-RNA binding during
HIV-1 virion genesis.
RESULTS
CLIP Assay for HIV-1 Gag-RNA Binding
We employed recently developed CLIP approaches (Hafner
et al., 2010; Licatalosi et al., 2008) to identify RNA molecules
bound by HIV-1 Gag protein during particle genesis. To facilitate
the purification of Gag-RNA adducts, we generated HIV-1NL4-3
(subtype B) and HIV-1NDK (subtype D) proviral clones carrying
an inactivating mutation in the viral protease and three consecu-
tive copies of a HA-tag within the stalk region of MA (MA-3xHA/
PR). The MA modification did not affect Gag expression or as-
sembly and had only a small effect on the infectiousness of a PR+
virus (Figures S1A and S1B available online). Cells transfected
with HIV-1NL4-3(MA-3xHA/PR
) proviral plasmids were grown
in the presence of ribonucleoside analogs (4SU or 6SG), which
also had minimal effects on infectious virion yield (Figures S1C
and S1D).
Cells and virions were UV-irradiated, lysed, and digested with
ribonuclease A. Then, Gag-RNA adducts were immunopurified,
end-labeled with g-32P-ATP, and visualized after SDS-PAGE
and transfer to nitrocellulose membranes. Gag-RNA adduct
formation was dependent on UV irradiation in cells and virions
(Figure 1A). We primarily used 4SU-based CLIP thereafter,
because it efficiently generated crosslinks, whereas 6SG and
unmodified RNA was used for confirmatory purposes. Gag-
crosslinked RNA oligonucleotides were purified, sequenced,
and mapped to the HIV-1 and human genomes (see Extended
Experimental Procedures). Reads derived from the terminal
repeat (R) region of the HIV-1 genome ambiguously map to 50
and 30 ends but are displayed at 50 end of the viral genome,
and cautiously interpreted, in our analyses.




cells, 2.5%–7% of the total reads were HIV-1 derived, whereas
60%were from host cell RNA (Figure 1B; Table S1). In compar-Cison, RNA sequencing (RNA-seq) libraries, which measure the
abundance of cellular and viral RNAs, contained 0.3%–1.6% of
reads derived from HIV-1, and 75% were from cellular RNA
(Figure 1B; Table S1). In immature virions, 50% and 20% of
CLIP reads were from viral and host RNAs, respectively (Fig-
ure 1B; Table S1), broadly similar to RNA abundance as deter-
mined by RNA-seq (Figure 1B). Thus, viral RNA sequences
were somewhat selectively bound by Gag in cells but were en-
riched to a far greater extent in virions.
HIV-1 RNA Sequences Bound by Gag in Cells and Virions
We plotted the frequencies with which each nucleotide in the
HIV-1NL4-3 genome was represented in reads from cell- and
virion-derived HIV-1NL4-3(MA-3xHA/PR
) Gag-CLIP libraries
(‘‘read density’’, Figure 1C). In cells, a major proportion of the
Gag-linked reads were derived from discrete sites in the viral
genome. As might be expected, the 50 leader was a frequent
site of Gag binding. However, additional sites of frequent Gag
binding included the RRE, sequences overlapping the Nef start
codon, and untranslated sequences in U3 (Figure 1C). Several
other sites on the viral genome were bound by Gag, but
at lower frequencies. The distribution of Gag-crosslinked viral
RNA reads was highly reproducible in HIV-1NL4-3(MA-3xHA/
PR) Gag CLIP-seq libraries as indicated by the nearly perfect
correlation between independent experiments (Figure 1D).
However, when a divergent HIV-1NDK strain was included in
these analyses, the only prominent Gag binding sites that
were present in both strains were the 50 leader and RRE
(Figure 1C).
The frequency with which Gag was crosslinked to sites across
the viral genome was starkly different in immature virions. Sites
of frequent Gag binding on HIV-1NL4-3 RNA were far more
numerous in immature virions than in cells. Moreover, specific
Gag binding to the 50 leader and RRE was not evident in imma-
ture virions (Figure 1C). The pattern of Gag binding frequency
across the viral genome was highly reproducible (Figure 1D)
and was unlikely to be generated by methodological bias during
CLIP-seq library generation, because it was largely unaffected
by the choice of ribonucleoside analog (4SU versus 6SG; Figures
S1E and S1F), ribonuclease (RNase A versus RNase T1; Figures
S1G and S1H), or the immunoprecipitating antibody (anti-HA
versus anti-NC; Figures S1I and S1J) used to generate the
CLIP libraries. HIV-1NDK Gag similarly bound to sites throughout
the viral genome (Figure 1C). Despite overall similarity, there
were some clear discrepancies in viral RNA sites that were
frequently occupied by HIV-1NL4-3 and HIV-1NDK Gag (Figures
1E and S1K), presumably due to differences in target RNA
sequence, or subtle differences in the RNA binding specificities
of the two Gag proteins.
The 3xHA tag did not affect the pattern of Gag binding at sites
proximal or distal to the insertion site (Figure S1L). Moreover,
autocorrelation analysis of Gag binding frequency revealed no
peaks other than at a separation of s = 0 (Figure S1M). Thus,
the frequency with which a given site in the viral genome was
bound by Gag in immature virions appeared unaffected by its
position relative to the J sequence or other Gag binding sites.
Rather, Gag binding appeared to be a function of local nucleo-
tide sequence or structure.ell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc. 1097
Figure 1. Viral RNA Binding by Gag in Cells and Virions
(A) Gag-RNA adducts immunoprecipitated fromHIV-1NL4-3(MA-3xHA/PR
)-expressing, 4SU- or 6SG-fed, cells or progeny virions, visualized by autoradiography
(upper). Western blot analysis of the same membranes (lower).
(B) Proportion of reads thatmap to cellular and viral genomes obtained fromGag-CLIP and RNA-seq experiments performed on cell lysates and immature virions.
Each point represents a separate library.
(C) Frequency distribution of nucleotide occurrence (read density) in reads mapping to viral genomes. A schematic diagram of HIV-1 genome features shown
above is colinear.
(D) Correlation analysis of HIV-1NL4-3 Gag binding to viral RNA in cells and virions from independent CLIP experiments.
(E) Correlation analysis of HIV-1NL4-3 versus HIV-1NDK Gag binding to viral RNA in virions.
See also Figure S1 and Table S1.Analysis of Gag Binding to 50 Leader and RRE
In cells, the most prominent Gag binding sites on the viral
genome coincided with the most prominently structured ele-
ments in the HIV-1 genome, namely, the 50 leader and the RRE
(Figure 1C). However, Gag was not bound across the 50 leader
and the RRE with uniform frequency, but selectively associated
with small determinants within these structures. In the case of
the 50 leader, Gag was most frequently bound to three distinct
sequences, including one at the 50 end of U5, a second site be-
tween the PBS and the major splice donor, and a third site 30 to
the major splice donor (Figure 2A). These sites are separated
from each other in linear sequence by approximately 100 nucle-1098 Cell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc.otides. Strikingly, however, a nuclear-magnetic-resonance-
based analysis of the structure of a J sequence (Lu et al.,
2011a) predicts that these three Gag-binding sequences would
be in close proximity, and partly base paired with each other
upon RNA folding into a structure that favors genome packaging
(Figure 2B).
Frequent Gag binding to the RRE occurred in stem I, a site
clearly distinct from the primary site of Rev-RRE interaction in
stem-loop IIB (Malim et al., 1990) (Figures 2C and 2D). Impor-
tantly, the Gag-bound reads derived from both the 50 leader
and RRE contained high rates of T-to-C substitution, identifying
individual nucleotide bases that were in close proximity to Gag
Figure 2. Details of HIV-1 Gag Binding toJ and RRE
(A and B) Read density distribution (red) and T-to-C mutations (blue) within the 50 leader (nucleotides 1–400, A) and RRE (B) in Gag-CLIP experiments with
HIV-1NL4-3 and HIV-1NDK.
(C and D) Depiction of read density distribution in the context of predicted secondary structures of the 50 leader (nucleotides 1–400, C) and RRE (D) in Gag-CLIP
experiments with HIV-1NL4-3 and HIV-1NDK. Color intensity represents read density indicated in the key.
See also Figure S2.(Figures 2A and 2C). Additionally, CLIP-seq experiments per-
formed using 4SU or 6SG yielded a similar footprint of Gag on
viral RNA, with 50 leader and RRE binding prominently featured
(Figures S2A and S2B). Thus, the apparently specific binding
of Gag to these sequence elements was not an artifact of the
particular crosslinking nucleotide used.CChanges in Gag RNA Binding to Viral RNA during HIV-1
Virion Assembly
Given the stark differences in the interaction of Gag with viral
RNA in cells and immature virions, we attempted to determine
what triggers this dramatic change. To this end, cells were frac-
tionated after UV irradiation (Figure 3A), and Gag-RNA adductsell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc. 1099
Figure 3. Changes in Gag Binding to Viral RNA during Virion Assembly and Maturation
(A) Western blot analysis of Gag, and markers of cytosol (LC3A/B) and plasma membrane (Na-K ATPase) in fractionated, 4SU-fed 293T cells transfected with a
HIV-1NL4-3(MA-3xHA/PR
) proviral plasmid.
(B) Autoradiogram of Gag-RNA complexes recovered from fractions in CLIP assays.
(C) Read density distribution on viral RNA from CLIP experiments in which WT and mutant Gag proteins were immunoprecipitated from cell fractions.
(D) Correlation analysis of CLIP data from cell fractions and immature virions.
(E) Autoradiogram of NC-RNA and Gag-RNA complexes recovered from mature and immature virions using an anti-NC antibody.
(F) Read density distribution on viral RNA fromCLIP experiments in whichGag andNCproteins were immunoprecipitated from immature andmature virions using
an anti-NC antibody.
(G) Correlation analysis of CLIP data from cells and mature and immature virions.
See also Figure S3.were immunoprecipitated from cytosol, in which Gag is primarily
monomeric, and from a membrane fraction where multimerized
assembly intermediates form (Kutluay and Bieniasz, 2010) (Fig-
ure 3B). The RNA binding profile of cytosolic Gag was nearly
indistinguishable from that described above for total cell lysates,
with J and RRE representing specific binding sites (Figures 3C1100 Cell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc.and 3D). Similarly, a myristoylation-defective Gag mutant
(Gag-G2A), which does not bind efficiently to membranes, was
also restricted to discrete binding sites on viral RNA (Figure S3A).
Conversely, Gag that was immunoprecipitated from membrane
fractions was bound to many sites on the viral genome, and,
although binding toJ and RRE remained prominent, the overall
Figure 4. Gag Binding to Viral RNA in the
Absence ofJ
(A) Western blot analysis (anti-HA) of Gag protein
expression from WT and J-deleted (D105-278
and D105-278/D301-332) proviral plasmids.
(B) Proportion of reads from cell and virion CLIP
experiments that map to cell and viral genomes,
following transfection of WT orJ-deleted proviral
plasmids. Each point represents a separate
library.
(C) Read density distribution on viral RNA from
CLIP experiments in which Gag proteins were
immunoprecipitated from cell lysates and imma-
ture virions following transfection with J-deleted
proviral plasmids.
(D) Correlation analysis of CLIP data from cells and
virions using WT andJ-deleted proviral plasmids.
See also Figure S4.RNA binding profile of cell-membrane-associated Gag other-
wise resembled that of immature virion-associated Gag (Figures
3C, 3D, and S3B). A late-domain mutant Gag protein (Dp6) was
similarly bound to sites throughout the viral genome (Figure 3C)
indicating that the completion of budding was not required for
this apparent shift in RNA binding specificity. Notably, a Gag
CADCTD mutant that is fully competent to localize to the plasma
membrane but is significantly impaired in the formation of high-
order multimers (Kutluay and Bieniasz, 2010) exhibited a binding
profile that was more reminiscent of cytosolic Gag, although
additional sites in the viral genome were bound with some
prominence (Figure 3C). Together, these data indicate that
high-order oligomerization of Gag at the plasma membrane
drives a profound change in Gag’s RNA-binding properties (Fig-
ure 3C, 3D, and S3B), dramatically increasing the extent to which
Gag and viral RNA interact with each other.
Changes in Gag-Viral RNA Binding Triggered by Virion
Maturation
Gag undergoes proteolytic cleavage during virion maturation,
liberating NC, which is then thought to condense with the viral
RNA inside a remodeled conical core (Sundquist and Kra¨usslich,Cell 159, 1096–1109, No2012). To determine whether virion matu-
ration affects Gag-viral RNA interactions,
we did CLIP experiments using an anti-
body that specifically recognizes NC (Fig-
ures S3D and S3E) and could efficiently
immunoprecipitate Gag-RNA and NC-
RNA adducts from immature and mature
virions, respectively (Figure 3E). Compar-
ison of RNA sequences bound by Gag
in immature virions and NC in mature vi-
rions revealed profound changes accom-
panying virion maturation (Figures 3F and
3G). Unlike intact Gag in immature vi-
rions, NC in mature virions preferentially
occupied discrete sequences on the viral
genome, that coincided in large part with
the major sites of Gag-viral RNA interac-tion in the cytosol (i.e., J and RRE) (Figures 3F and 3G). Many
of the additional prominent NC-binding sites in mature virion
RNA were also bound by intact Gag in the cytosol at lower fre-
quencies (Figure S3F). Thus, the RNA-binding properties of NC
in mature virions resemble that of unassembled Gag in the
cytosol to a surprising extent, exhibiting statistically significant
correlation (Figure 3G), possibly reflecting the monomeric state
of cytosolic Gag and mature NC.
Gag Binding to Viral RNA and Viral RNA Packaging in the
Absence ofJ or RRE
To test the importance of the Gag/NC-binding sites in J and
RRE, we generated viruses carrying deletions of these se-
quences. First, we determined whether the Gag binding to addi-
tional sites on the viral genome in cells and in virions required
initial binding toJ. To this end, we performed CLIP experiments
using viral constructs carrying deletions of two of the three
Gag-binding sequences (D105-278), or all three Gag binding se-
quences (D105-278/D301-332) within J. These deletions left
sequences surrounding the major 50 splice donor intact, and
only modestly reduced Gag expression (Figure 4A). Surprisingly,
in cells, neither the D105-278 nor the D105-278/D301-332vember 20, 2014 ª2014 Elsevier Inc. 1101
mutation affected the fraction of Gag-crosslinked reads derived
from viral versus human genomes (Figure 4B). Moreover, in
immature virions, these J-deletions caused only a modest 3-
fold decrease in the fraction of reads derived from the viral
genome, with a corresponding increase in the fraction of reads
from cellular RNAs (Figure 4B). The pattern of Gag binding to viral
RNA in cells was not greatly affected by theJ deletions (Figures
4C and 4D), although there was an apparent reduction in the
frequency with which RRE was bound. Similarly, the overall
pattern of Gag binding to viral RNA in immature virions was
also relatively unperturbed by J deletions (Figures 4C, 4D, and
S4A). However, there was a tendency for read densities to
increase toward the 30 end of the viral genome, perhaps reflect-
ing the incorporation of spliced viral RNAs into virions generated
byJ-deleted genomes (Clever and Parslow, 1997; Houzet et al.,
2007; Russell et al., 2003). Importantly, these results indicate
that multiple sites on the viral genome bind to Gag independently
of J and facilitate HIV-1 genome packaging.
To analyze the effects of Gag-RRE interaction on HIV-1 infec-
tivity, we generated viruses in which Rev was deleted and the
nuclear export of unspliced viral RNAs was mediated by the
Mason-Pfizer monkey virus constitutive transport element
(CTE) to circumvent effects of RRE on RNA nuclear export (Fig-
ure S4B). In this setting, the presence or absence of RRE had no
discernible effect on Gag protein levels or infectious virus yield
(Figure S4C). Although it is formally possible that the MPMV
CTE might recapitulate the Gag-binding properties of RRE, this
analysis suggests that Gag RRE interactions do not regulate
Gag expression and are not required for RNA packaging.
Changes in the Sequence Specificity of Gag RNA
Binding during Virion Genesis
Theaforementioned results suggest adegreeof redundancy, and
contributions from multiple domains of the viral genome to RNA
packaging. In an attempt to explain the factors driving the selec-
tivitywithwhichGagbound to andpackaged viral RNA,wedeter-
mined the identities of cellular mRNA sequences that were most
frequently bound toGag in cells and in virions. Reads that aligned
to the human genomewere clustered using PARalyzer (Corcoran
et al., 2011), which defines a cluster, or binding site, based on the
occurrence of a minimum number overlapping reads proximal to
a T-to-C substituted crosslinking site in 4SU-based CLIP assays
(Table S2). Note that a single cluster is counted once for the
analysis shown in Figure 5A, irrespective of the number or reads
associated with it. In cells, >90% of clusters (Gag binding sites)
werewithin genes, and80%of thesewere derived frommRNAs
(Figure 5A) with an overlap of >95% between HIV-1NL4-3 and
HIV-1NDK Gag-bound mRNA clusters (Figure S5A). A similar
analysis of immature virions generated a collection of clusters
that were also mostly derived frommRNAs (Figure 5A) and over-
lapped by >70% in HIV-1NL4-3 and HIV-1NDK libraries. Notably,
greater discrepancies were observed when the Gag-binding
clusters in cells versus virions were compared (Figure S5A),
indicating that many mRNA sequences that are preferred Gag
binding sites in cells are not preferred binding sites in virions
and vice versa.
We counted the number of reads associated with each cluster
and determined the 100 sites in cellular mRNAs that were most1102 Cell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc.frequently bound by Gag in cells and immature virions. The
nucleotide composition of these Gag binding sites revealed a
striking change in the RNA binding preference of Gag during
virion genesis (Figure 5B). In cells, preferred Gag binding sites
had a strong tendency to be G-rich (mean G-content of
40%). In contrast, in immature virions, preferred Gag binding
sites displayed a tendency to be A-rich. Remarkably, the nucle-
otide content of the preferred Gag binding sites in cellular
mRNAs associated with immature virions was strikingly similar
to the nucleotide composition of the HIV-1 genome.
We used cERMIT (Georgiev et al., 2010), to search for
sequence motifs that were enriched in Gag-bound cellular
mRNA clusters recovered at various stages of virion genesis.
G/U-rich sequence motifs were the most often present in host
mRNA sequences bound to Gag in the cytoplasm (Figure 5C).
At the plasma membrane, and particularly in immature virions,
there was a clear change in binding specificity. Here, Gag
bound more frequently to A-rich and A/G-rich cellular mRNA
motifs (Figure 5C). Inspection of the sequences of the 12 clus-
ters most frequently bound by Gag in the viral genome, in imma-
ture virions, revealed multiple instances of similar A/G-rich
motifs scattered in the viral genome (Figure 5D). In mature vi-
rions, RNA binding specificity reverted, and the sequence mo-
tifs favored by NC were again G/U-rich. These findings reinforce
the notion that Gag binds preferentially to RNAs that have an
A-rich nucleotide composition, and particularly to A-rich motifs
that are present in the viral genome, transiently during immature
virion assembly.
tRNAs Are theMost Frequently Gag-Bound RNA in Cells,
but Not in Virions
Although the aforementioned analysis focused on Gag binding
to mRNA sequences, when the number of individual Gag-bound
reads associated with each cluster or binding site was counted,
it was evident that mRNAs were responsible for only a fraction
(12%) of the cellular RNA reads crosslinked to Gag. In fact,
tRNAs were the dominant RNA species bound by Gag in cells
(60%–70% of reads), with 7SL RNA, a known component of
HIV-1 virions (Onafuwa-Nuga et al., 2006) constituting the bulk
of the remaining reads (Figure 6A). Strikingly, the fraction
tRNA-derived reads was greatly reduced in CLIP-seq libraries
prepared from virions as compared to cells. This was not the
case for other RNA classes, suggesting that tRNAs were specif-
ically excluded from Gag-bound RNAs in virions (Figure 6A).
MA Binds to Particular tRNAs
Although the aforementioned Gag-RNA binding events were
assumed to involve the NC domain of Gag, there are numerous
reports that MA can interact with viral or cellular RNAs (reviewed
in Alfadhli and Barklis, 2014). However, these interactions,
generally assayed in vitro, are of uncertain significance. To test
whether MA binds to RNA in cells, we modified the aforemen-
tioned HIV-1NL4-3(MA-3xHA/PR
) clones to include a FXa prote-
ase cleavage site immediately N- or C-terminal to the 3xHA-tag
(Figures 6B and S6A). After UV crosslinking, cell lysates could be
treated with FXa protease to generate two Gag fragments (MA
and CA-NC-p6) only one of whichwould be tagged and immuno-
precipitated (Figures 6B and 6C).
Figure 5. Changes in Gag-RNA Binding Specificity during Virion Genesis
(A) Classification of PARalyzer-generated read clusters that map to cellular RNAs; total number of clusters is indicated.
(B) Nucleotide composition of 100 PARalyzer-generated clusters with largest numbers of reads, derived from Gag-bound host mRNAs in cells and immature
virions. Larger white circle symbols indicate nucleotide composition of the HIV-1 genome.
(C) Sequence motifs identified by cERMIT as most frequently occurring in Gag bound, host cell mRNA clusters at various steps of virion genesis. Cumulative
percentages of clusters containing the motifs are indicated.
(D) Sequences of the 12 viral genome-derived clusters that are most frequently Gag-bound in immature virions. Motifs matching those identified as preferred
binding sites in host mRNAs are highlighted in blue.
See also Figure S5 and Table S2.Like full-length Gag, the immunoprecipitated CA-NC-p6 con-
tained crosslinked RNA species that caused adducts to migrate
0–10 kDa above the expected molecular weight of the protein.
Notably, the isolated MA domain also generated prominent
crosslinked species, indicating RNA binding. Unusually, these
MA-RNA adducts migrated at a discrete molecular weight of
35 kDa, suggesting that MA bound to a unique RNA species
(Figure 6D).
Although the CA-NC-p6-RNA adducts contained viral RNA se-
quences with a very similar distribution to those recovered fromCfull-length Gag, MA-RNA adducts were nearly devoid of viral
RNA-derived sequence (Figure 6E). In fact, the RNA molecules
crosslinked to MA were almost exclusively host tRNAs (Fig-
ure 6F). When RNase treatment was omitted from the CLIP pro-
cedure prior to immunoprecipitation, MA-RNA adducts migrated
at a larger, but still discrete, molecular weight (Figure 6D) match-
ing the size of one tRNA molecule (20 kDa) crosslinked to MA,
suggesting that MA binds to full-length tRNAs.
Although tRNAs constituted the majority of cellular RNAmole-
cules bound by intact Gag in cells, deletion ofMA caused amajorell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc. 1103
Figure 6. HIV-1 MA Binds to Specific tRNAs, but Not Viral RNA
(A) Classification of individual reads from cell and immature virion Gag-CLIP experiments that map to genes in the host cell genome.
(B) Schematic representation of FXa-cleavable Gag proteins.
(C and D) Western blot analysis (anti-HA, C) and autoradiography (D) of immunoprecipitated (anti-HA) proteins from HIV-1NL4-3 MA-FXa-3xHA/PR
- and MA-
3xHA-FXa/PR-transfected cells that were subjected to the modified CLIP procedure. Cell lysates were treated with Factor Xa protease, with or without RNase A
prior to immunoprecipitation. *Breakdown products of the 3xHA-CA-NC-p6 protein that retain the HA tag but are not crosslinked to RNA.
(E) Read density distribution on viral RNA following CLIP analysis of FXa-liberated 3xHA-CA-NC-p6 and MA-3xHA proteins.
(F) Classification of individual reads that map to cellular genes from cell associated Gag-CLIP experiments employing the FXa-liberated MA-3xHA protein or WT
and mutant, uncleaved Gag proteins. Total number of reads is indicated below.
(G) Numbers of reads crosslinked to FXa-liberated MA-3xHA or uncleaved Gag proteins that lack NC (DNC) and MA (DMA) that map to each tRNA gene.
(H) Two examples of read density distributions (red) and T-to-C substitutions (blue) at crosslinking sites on tRNAs (Gly[GCC] and Lys[TTT]) following CLIP analysis
of FXa-liberated MA-3xHA.
See also Figure S6.reduction in the fraction of reads that were tRNA derived but did
not inhibit binding to mRNAs or 7SL RNA (Figures 6F and S6B).
Conversely, a mutant Gag protein lacking the NC domain did not
bind mRNA or 7SL, but bound nearly exclusively to tRNAs (Fig-1104 Cell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc.ures 6F and S6B). Progressive and specific loss of tRNA binding
occurred as more lysines in the N-terminal MA basic domain
were substituted, and mutation of six lysines (MAK6T) reduced
Gag-tRNA binding to the same degree as deletion of MA (Figures
Figure 7. Reciprocal Relationship between HIV-1 Gag Binding to RNA and Membrane during Virion Genesis
(A) Western blot analysis (anti-CA and anti-b-tubulin) of HOS cell lysates, fractionated by membrane flotation after treatment with RNase.
(B) Quantitation of Gag and b-tubulin in the cytosol and membrane fractions from five independent experiments each with HOS and HeLa cells.
(C) Classification of individual reads that map to genes in the host cell genome from Gag-CLIP experiments done using fractionated cells and WT or mutant Gag
proteins as described in Figure 3. Total number of reads is indicated below.
(D) Model summarizing changing interactions between Gag and RNA during virion genesis.6F and S6B). As expected, MAK4T and MAK6T mutations
caused decreases in the levels of released particles (Figure S6B),
consistent with a plasma membrane targeting defect in these
mutants.
MA binding to tRNAs was highly selective. Indeed, GluCTC,
GluTTC, GlyGCC, GlyCCC, LysCTT, LysTTT, ValAAC, and
ValCAC tRNAs were bound up to 100-fold more frequently
than the majority of tRNAs (Figure 6G). No such enrichment
occurred in CLIP experiments done with GagDMA. Although
intact tRNA molecules were bound by MA (Figure 6D), binding
apparently involved the 50 half of the tRNA molecules, and espe-
cially the dihydrouridine loop, as indicated by the very high rates
of T-to-C conversions at this site (Figure 6H). Binding was not
induced by 4SU incorporation into tRNAs, because the same
tRNAs were selectively MA-bound in CLIP experiments where
crosslinking was induced by UV irradiation at 254 nm in the
absence of modified nucleotides (Figure S6C).
Regulation of Gag Membrane Binding by tRNA
The finding that the same lysine residues that mediate plasma
membrane binding also mediate tRNA binding, suggested that
tRNAs might regulate Gag localization. Indeed, previous work
has indicated that exogenous RNA can inhibit Gag binding to
liposomes in vitro (Chukkapalli et al., 2010, 2013; Dick et al.,
2013). We took a simple cell-based approach (without addition
of exogenous RNA or liposomes) and tested whether RNaseCtreatment of cell lysates increased Gag binding to endogenous
cellular membranes. Lysates of HeLa and HOS cells stably
expressing Gag-CFP were treated with ribonucleases and sub-
jected to membrane flotation analysis. Strikingly, RNase treat-
ment caused a significant redistribution of Gag from cytosol to
membrane fractions (Figures 7A and 7B), whereas a control pro-
tein, b-tubulin, was largely unaffected. Consistent with a model
in which tRNAs compete with membranes for Gag binding,
tRNAs comprised a significantly smaller fraction of Gag-bound
RNAs at the plasmamembrane than in the cytoplasm (Figure 7C).
This difference was more pronounced when particle budding
was blocked at the plasma membrane by deletion of the late
budding domain of Gag (Figure 7C). Thus, these results indicate
that MA can bind to tRNA or cell membranes, but not both
simultaneously, and strongly suggest that tRNAs regulate Gag
localization by binding to basic amino acids in MA.
DISCUSSION
Two central conclusions of these studies are (1) the HIV-1 Gag
protein has two RNA binding domains (NC and MA) with very
different specificities and (2) dramatic changes in RNA binding
regulate Gag localization and genome packaging during virion
genesis (Figure 7D).
Prior to virion assembly, Gag exists as a diffuse pool of mono-
mers or low-order multimers in the cytoplasmwith its NC domainell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc. 1105
bound primarily to mRNA, with some binding to 7SL and tRNA
(Figure 7D). A fraction of NC-RNA interactions are with particular
sites on the HIV-1 genome, including theJ sequence. Our data
reveal the specific RNA sequences withinJ that are in proximity
to Gag, in a physiological setting. Satisfyingly, the three noncon-
tiguous RNA elements that are most frequently crosslinked to
Gag (nucleotides 100–126, 195–260, and 300–350) coincide
nearly precisely with a minimal J element, which adopts a sec-
ondary structure that putatively favors genome packaging (Lu
et al., 2011a).
Surprisingly, cytoplasmic Gag bound to additional discrete
elements on the viral RNA, including RRE. Previously, env se-
quences, including RRE, were shown to facilitate packaging
(Kaye et al., 1995; Richardson et al., 1993), but a discrete pack-
aging sequence within env could not be mapped. Other reports
suggest that Rev enhances packaging (Brandt et al., 2007),
although effects of Rev/RRE on viral RNA nuclear export are
potential confounders in packaging experiments. Despite strong
evidence for Gag-RRE binding, the RRE did not affect infectious
virion yield when its nuclear export function was replaced, sug-
gesting that Gag-RRE binding is not required for genome pack-
aging. Although it is possible that Gag/NC-RRE interaction plays
a redundant role in packaging, other plausible functions include
(1) shielding double-stranded stem I RNA from cytoplasmic sen-
sors, (2) coupling RNA-export with packaging, (3) displacement
of Rev from the RRE for recycling, (4) regulation of Env transla-
tion, and (5) enhancement of reverse transcription via NC’s
unwinding/chaperone function (Levin et al., 2010). Further work
will be required to elucidate the functional role, if any, of Gag/
NC-RRE binding.
In the cytosol, Gag favored binding to the viral genome over
cellular mRNAs by a few fold. This level of discrimination is insuf-
ficient to account for the selectivity with which viral genomes are
packaged. Our data indicate that a dramatic change in Gag-RNA
binding specificity, coincident with CA-CTD-dependent high-
order multimerization at the plasma membrane, contributes to
selective packaging (Figure 7D). GU-rich sequences in cellular
mRNA were targeted by Gag in the cytosol, consistent with pre-
vious in vitro and structural studies indicating that the isolated,
monomeric NC domain favors binding to such sequences
(Berglund et al., 1997; De Guzman et al., 1998; Fisher et al.,
1998). However, during assembly, Gag molecules become
tightly packed in hexameric lattices (Briggs et al., 2009; Wright
et al., 2007). By constraining thousands of NC domains into a
pseudo-2D curved array, local NC concentration is dramatically
elevated. Potentially, features of NC that govern RNA binding
specificity (zinc knuckles and basic amino acids) might be differ-
ently accessible in an assembled Gag lattice. Under these
conditions, we found that A-rich mRNA sequences were prefer-
entially bound by Gag (Figure 7D). Remarkably, the nucleotide
composition of mRNA sequences bound by assembled Gag re-
flects an unusual, heretofore unexplained, property of the HIV-1
genome. Thus, our findings suggest that a need to selectively
package viral RNA caused HIV-1 to evolve an unusually A-rich
genome. Conversely, an A-rich genome may have evolved for
other reasons and then drove Gag to gain a unique oligomeriza-
tion-driven specificity for A-rich RNA. Notably, J-deletion
caused only a 3-fold reduction in the fraction of virion-associ-1106 Cell 159, 1096–1109, November 20, 2014 ª2014 Elsevier Inc.ated, Gag-bound, RNA sequences that were viral RNA derived.
Moreover, the pattern of Gag binding to many sites in the viral
genome was not solely a secondary effect of physical proximity
to Gag-J interactions. Rather, it appears that HIV-1 genome
packaging is a two-step process, involving interactions between
(1)J andmonomeric Gag and (2) A-rich viral RNA andmultimeric
Gag. This scenario should selectively drive particle assembly
on viral RNAs, and we speculate that the biases in nucleotide
composition exhibited by HIV-1 and other retroviruses serves
as a proofreading-like mechanism to enhance the fidelity of
genome packaging following initial Gag-J interaction.
An unexpected finding was that proteolytic cleavage of Gag
caused NC to revert to a preference for GU-rich mRNAs and
discrete viral RNA sequences. This result reinforces the notion
that Gag/NC RNA binding specificity is multimerization depen-
dent. By liberating the majority of viral RNA from NC, while
maintaining interaction with structured elements (to enable
NC’s chaperone activity), maturation-dependent changes in
Gag/NC-RNA binding could facilitate reverse transcription (Levin
et al., 2010).
Another surprising finding was that MA binding to specific
tRNAs constitutes the most frequent binding events between
Gag and RNA in cells. MA-tRNA binding was independent of
NC and the PBS and is thus unlikely to involve the tRNA primer
annealed to viral genome. Rather, we found that MA-tRNA inter-
action could regulate the binding of Gag to cellular membranes.
MA specifies the location of virion assembly, and it was previ-
ously shown that RNA can block in vitro MA binding specifically
to liposomes that lack acidic phospholipids (Chukkapalli et al.,
2010, 2013). Thus, occlusion of MA basic residues by specific
tRNAsmight inhibit nonproductive assembly atmost intracellular
membranes and facilitate targeting to the plasma membrane
where resident lipids have a high affinity for MA. Alternatively,
MA-tRNA binding might provide a mechanism by which virion
assembly is temporally regulated.
MA-tRNA interactions could serve additional purposes. Some
degree of RNA binding may be an inevitable consequence of en-
coding a highly basic domain. Thus, specific MA binding in a 1:1
complex to small RNAs might be a mechanism to avoid the
aggregation of a protein that has both two distinct RNA binding
domains and a tendency to multimerize. MA-tRNA binding might
also prevent nonproductive interaction of a viral genome with
a Gag monomer whose NC domain has engaged viral RNA.
Conceivably, MA may facilitate the selection of the RT primer,
as tRNAlys3 is among the tRNAs bound byMA, but several other
tRNAs are also bound by MA more frequently. Finally, MA-tRNA
interaction could regulate viral and/or host translation. The A-
richness of the HIV-1 genome results in suboptimal codon usage
(Grantham and Perrin, 1986; Kypr and Mra´zek, 1987; Sharp,
1986) and an elevated number of Ile, Lys, Glu, and Val codons
in the Gag and Pol ORFs (Berkhout and van Hemert, 1994).
Notably, Lys, Glu, and Val tRNAs are among those specifically
bound by MA, providing a potential opportunity for Gag to regu-
late its own translation as it accumulates to high levels and
sequesters tRNAs (perhaps facilitating packaging as a conse-
quence). Similarly, MA could inhibit translation of host mRNAs
whose products may be deleterious for viral replication. Indeed,
interaction of MA with host elongation factors via a tRNA bridge
has been reported to inhibit translation in vitro (Cimarelli and
Luban, 1999).
Overall, our global survey reveals surprising ways in which the
interaction between Gag, viral, and host RNAs can change and
modulate the process of virion genesis and genome packaging.
EXPERIMENTAL PROCEDURES
Proviral Plasmids and Cells
HIV-1NL4-3-derived proviral plasmids containing a 3xHA tag in the stalk region
ofmatrix (HIV-1NL4-3MA-3xHA)were constructed usingoverlap extensionPCR.
Various derivatives of this construct encoding a catalytically inactive viral
protease (PR), a Factor Xa cleavage site on either side of the HA tag (MA-
FXa-3xHA and MA-3xHA-FXa), deletions of nucleocapsid domain (DNC), the
globular head of MA (DMA), the CA CTD (CA DCTD), or the J signal (D105-
278 and D105-278/D301-332) were constructed using PCR-based deletion
mutagenesis. Constructs carrying mutations at binding sites for Tsg101 and
ALIX proteins in the p6 domain of Gag (Dp6), the Gag myristoylation signal
(G2A), or at lysine residues in MA (MAK26,27T MAK4T and MAK6T) were con-
structed using PCR overlap extension-based mutagenesis. Proviral plasmids
with deletions ormutations in Env, Rev, and RRE and encoding aMason-Pfizer
monkey virus constitutive transport element were similarly constructed. Details
of the construction are described in Extended Experimental Procedures.
PAR-CLIP, HITS-CLIP, and RNA-Seq
For CLIP experiments, HEK293T cells were grown in 10 cm dishes and trans-
fected with proviral plasmids using polyethylenimine (PolySciences). Virions
were harvested from filtered supernatant by ultracentrifugation through su-
crose andUV irradiated, whereas cells were irradiated while adhered to culture
dishes. Prior to UV crosslinking, a fraction of cells and virions were collected
for RNA-seq analysis. After crosslinking, the CLIP procedure was performed
on unfractionated lysates (after removal of nuclei) or on membrane and cyto-
plasmic fractions.
For the CLIP procedure, cell and virion lysates were treated with RNaseA or
RNaseT1 and then incubated with Protein G-conjugated Dynabeads coated
with anti-HA or anti-NC antibodies. After immunoprecipitation of RNA-protein
adducts, beads were washed and treated sequentially with calf intestinal alka-
line phosphatase and then polynucleotide kinase and g-32P-ATP. RNA-protein
adducts were eluted from the beads, separated by SDS-PAGE, blotted onto
nitrocellulose, and digested with proteinase K. RNA oligonucleotides were
then ligated to adapters, amplified by PCR and sequences determined using
a Illumina HiSeq 2000 platform.
CLIP-seq experiments were performed two to six times on cells and virions.
Further details of the method are in the Extended Experimental Procedures.
Bioinformatic Analyses
The FASTX toolkit was used to process the reads from CLIP and RNA-seq
libraries before mapping. Reads were separated based on their 50 barcode
sequences and collapsed to generate a set of unique sequences. Unique
CLIP-seq and RNA-seq reads were mapped to the human (hg19) and HIV-1
genomes using the Bowtie. SAMtools, in house scripts, and GraphPad Prism
were used to calculate and display read densities associated with viral and
cellular RNAs and to calculate correlations. Clusters were generated using
PARalyzer and used as an input for the cERMIT motif finding tool. Further
details are given in the Extended Experimental Procedures.
Membrane Flotation Assays
The membrane flotation assays were performed using HeLa and HOS cells
stably expressing cyan fluorescent protein-tagged Gag proteins as described
(Kutluay and Bieniasz, 2010) with modifications outlined in the Extended
Experimental Procedures.
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